Molecular Insight Pharmaceuticals, Inc. (MIPI) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Director departure
Quarterly results
CC transcript

Molecular Insight Pharmaceuticals, Inc. (MIPI)

Create: Alert

All | News | Filings

Date Filed	Type	Description
12/17/2010	3	Attarian Mark A (Interim EVP & CFO) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc.
07/01/2010	3	Taconic Capital Advisors LP (Reference Footnote 1) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc.
06/30/2010	3	Pioneer Floating Rate Trust (Reference footnote 1.) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc.
06/30/2010	3	Pioneer Floating Rate Trust (Reference footnote 1.) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc.
06/30/2010	3	McDonnell Loan Opportunity Ltd. (See Remarks) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc.
06/30/2010	3	Form 3 - Initial statement of beneficial ownership of securities
08/12/2009	3	Abdalian Charles H Jr (VP of Finance & CFO) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc.
06/05/2009	3	PETERS DANIEL (President and CEO) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc.
02/10/2009	3	Looney Paul Anthony (COO) has filed a Form 3 on Molecular Insight Pharmaceuticals, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy